381 related articles for article (PubMed ID: 34696775)
1. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.
Li N; Dai Z; Wang Z; Deng Z; Zhang J; Pu J; Cao W; Pan T; Zhou Y; Yang Z; Li J; Li B; Ran P
Respir Res; 2021 Oct; 22(1):274. PubMed ID: 34696775
[TBL] [Abstract][Full Text] [Related]
2. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
3. Chronic exposure to ambient particulate matter induces gut microbial dysbiosis in a rat COPD model.
Li N; Yang Z; Liao B; Pan T; Pu J; Hao B; Fu Z; Cao W; Zhou Y; He F; Li B; Ran P
Respir Res; 2020 Oct; 21(1):271. PubMed ID: 33076910
[TBL] [Abstract][Full Text] [Related]
4. Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.
Chiu YC; Lee SW; Liu CW; Lan TY; Wu LS
Respir Res; 2022 Jan; 23(1):10. PubMed ID: 35033061
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota dysbiosis contributes to the development of hypertension.
Li J; Zhao F; Wang Y; Chen J; Tao J; Tian G; Wu S; Liu W; Cui Q; Geng B; Zhang W; Weldon R; Auguste K; Yang L; Liu X; Chen L; Yang X; Zhu B; Cai J
Microbiome; 2017 Feb; 5(1):14. PubMed ID: 28143587
[TBL] [Abstract][Full Text] [Related]
7. Alterations in gut microbiota of abdominal aortic aneurysm mice.
Xie J; Lu W; Zhong L; Hu Y; Li Q; Ding R; Zhong Z; Liu Z; Xiao H; Xie D; Zheng G; Ye B; Zhong Y; Liu Z
BMC Cardiovasc Disord; 2020 Jan; 20(1):32. PubMed ID: 31992206
[TBL] [Abstract][Full Text] [Related]
8. Fecal Bacteria Implicated in Biofilm Production Are Enriched and Associate to Gastrointestinal Symptoms in Patients With APECED - A Pilot Study.
Hetemäki I; Jian C; Laakso S; Mäkitie O; Pajari AM; de Vos WM; Arstila TP; Salonen A
Front Immunol; 2021; 12():668219. PubMed ID: 34367134
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease.
Lim EY; Song EJ; Shin HS
J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760
[TBL] [Abstract][Full Text] [Related]
10. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
Wu Y; Luo Z; Liu C
Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
[TBL] [Abstract][Full Text] [Related]
11. Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington's Disease.
Du G; Dong W; Yang Q; Yu X; Ma J; Gu W; Huang Y
Front Immunol; 2020; 11():603594. PubMed ID: 33679692
[TBL] [Abstract][Full Text] [Related]
12. Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome.
Opeyemi OM; Rogers MB; Firek BA; Janesko-Feldman K; Vagni V; Mullett SJ; Wendell SG; Nelson BP; New LA; Mariño E; Kochanek PM; Bayır H; Clark RSB; Morowitz MJ; Simon DW
J Neurotrauma; 2021 Sep; 38(18):2610-2621. PubMed ID: 33957773
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota modulates alcohol withdrawal-induced anxiety in mice.
Xiao HW; Ge C; Feng GX; Li Y; Luo D; Dong JL; Li H; Wang H; Cui M; Fan SJ
Toxicol Lett; 2018 May; 287():23-30. PubMed ID: 29391279
[TBL] [Abstract][Full Text] [Related]
14. Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A review.
Song W; Yue Y; Zhang Q
Biomed Pharmacother; 2023 Sep; 165():115150. PubMed ID: 37429232
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice.
Zhu Y; He C; Li X; Cai Y; Hu J; Liao Y; Zhao J; Xia L; He W; Liu L; Luo C; Shu X; Cai Q; Chen Y; Lu N
J Gastroenterol; 2019 Apr; 54(4):347-358. PubMed ID: 30519748
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity.
Chiu YC; Lee SW; Liu CW; Lin RC; Huang YC; Lan TY; Wu LS
PLoS One; 2021; 16(4):e0249944. PubMed ID: 33836012
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients.
Laiman V; Chuang HC; Lo YC; Yuan TH; Chen YY; Heriyanto DS; Yuliani FS; Chung KF; Chang JH
Respir Res; 2024 May; 25(1):204. PubMed ID: 38730440
[TBL] [Abstract][Full Text] [Related]
19. Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis.
Jing Y; Yu Y; Bai F; Wang L; Yang D; Zhang C; Qin C; Yang M; Zhang D; Zhu Y; Li J; Chen Z
Microbiome; 2021 Mar; 9(1):59. PubMed ID: 33678185
[TBL] [Abstract][Full Text] [Related]
20. Oral Sub-chronic Ochratoxin A Exposure Induces Gut Microbiota Alterations in Mice.
Izco M; Vettorazzi A; de Toro M; Sáenz Y; Alvarez-Erviti L
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33535685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
